Then, the results that ARID1A and BRCA2 were more frequently mutated in diffuse-type C-II GCs than in C-I GCs (Fig. 5b) suggest that many mutations may be induced in the tumor by the loss of function of these tumor suppressors. Here, BRCA2 is linked to neoplasm.